Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Experimental Toxicology and ZEBET | Statement: [Federal Institute for Risk Assessment, hasSection, Experimental Toxicology and ZEBET]

Target entity: Experimental Toxicology and ZEBET
Context triple: [Federal Institute for Risk Assessment, hasSection, Experimental Toxicology and ZEBET]

• A. Toxicology in the 21st Century program
  The Toxicology in the 21st Century program is a U.S. research initiative that uses modern high-throughput and computational methods to improve the prediction of chemical toxicity and reduce reliance on traditional animal testing.
• B. TOXNET
  TOXNET is an online database system providing access to toxicology, hazardous chemicals, and environmental health information developed by the U.S. National Library of Medicine.
• C. ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
  ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals is an international guideline that outlines the nonclinical safety testing requirements for biotechnological products such as therapeutic proteins and monoclonal antibodies to support their clinical development and marketing authorization.
• D. ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
  ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
• E. Division of Chemical Toxicology
  The Division of Chemical Toxicology is a specialized unit of the American Chemical Society that focuses on the chemistry of toxic substances and their effects on biological systems.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Experimental Toxicology and ZEBET
Triple: [Federal Institute for Risk Assessment, hasSection, Experimental Toxicology and ZEBET]

Experimental Toxicology and ZEBET is a specialized section of Germany’s Federal Institute for Risk Assessment focused on experimental toxicology and the development and promotion of alternative methods to animal testing.

Target entity: Experimental Toxicology and ZEBET
Target entity description: Experimental Toxicology and ZEBET is a specialized section of Germany’s Federal Institute for Risk Assessment focused on experimental toxicology and the development and promotion of alternative methods to animal testing.

• A. Toxicology in the 21st Century program
  The Toxicology in the 21st Century program is a U.S. research initiative that uses modern high-throughput and computational methods to improve the prediction of chemical toxicity and reduce reliance on traditional animal testing.
• B. TOXNET
  TOXNET is an online database system providing access to toxicology, hazardous chemicals, and environmental health information developed by the U.S. National Library of Medicine.
• C. ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
  ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals is an international guideline that outlines the nonclinical safety testing requirements for biotechnological products such as therapeutic proteins and monoclonal antibodies to support their clinical development and marketing authorization.
• D. ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
  ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
• E. Division of Chemical Toxicology
  The Division of Chemical Toxicology is a specialized unit of the American Chemical Society that focuses on the chemistry of toxic substances and their effects on biological systems.
• F. None of above. chosen